Literature DB >> 26687302

MicroRNA-144-3p inhibits proliferation and induces apoptosis of human salivary adenoid carcinoma cells via targeting of mTOR.

Fangyi Huo1, Chen Zhang2, Hong He3, Yunlong Wang4.   

Abstract

OBJECTIVES: To investigate the biological functions of microRNA-144-3p with respect to proliferation and apoptosis of human salivary adenoid carcinoma cell lines via mTOR.
RESULTS: After transfection of microRNA-144-3p agomir, cell viability assays confirmed that the salivary adenoid carcinoma cell (SACC) proliferation was inhibited and apoptosis was induced. Dual luciferase reporter assay validated that the mammalian target of rapamycin (mTOR) was a direct target of miR-144-3p. Western blot, immunofluorescent analysis and a xenograft mouse model of adenoid cystic carcinoma indicated that miR-144-3p was a tumor suppressor and repressed mTOR expression and signaling in SACCs.
CONCLUSIONS: MicroRNA-144-3p inhibits proliferation and induces apoptosis of human salivary adenoid carcinoma cells by downregulating mTOR expression in vitro and in vivo.

Entities:  

Keywords:  Adenoid cystic carcinoma; Apoptosis; MTOR; MicroRNA-144-3p; Proliferation

Mesh:

Substances:

Year:  2015        PMID: 26687302     DOI: 10.1007/s10529-015-2007-x

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  9 in total

1.  Induction of morphological and functional differentiation of human neuroblastoma cells by miR-124.

Authors:  Samaneh Sharif; Mohammad Hossein Ghahremani; Masoud Soleimani
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

2.  MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.

Authors:  Yue Zhao; Zhongshi Xie; Jie Lin; Peng Liu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification.

Authors:  Bin Han; Ke Xu; Dan Feng; Yang Bai; Yangqi Liu; Yuanyuan Zhang; Liming Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-27       Impact factor: 4.322

4.  Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells.

Authors:  Yong Wang; Yueyang Zhang; Tao Yang; Wei Zhao; Ningning Wang; Pengcheng Li; Xiandong Zeng; Weiguo Zhang
Journal:  Oncotarget       Date:  2017-07-31

5.  Mice endometrium receptivity in early pregnancy is impaired by maternal hyperinsulinemia.

Authors:  Runqin Li; Juan Wu; Junlin He; Yingxiong Wang; Xueqing Liu; Xuemei Chen; Chao Tong; Yubin Ding; Yan Su; Wenqi Chen; Chen Zhang; Rufei Gao
Journal:  Mol Med Rep       Date:  2017-03-14       Impact factor: 2.952

6.  Detrimental Role of miRNA-144-3p in Intracerebral Hemorrhage Induced Secondary Brain Injury is Mediated by Formyl Peptide Receptor 2 Downregulation Both In Vivo and In Vitro.

Authors:  Weijian Fan; Xiang Li; Dongping Zhang; Haiying Li; Haitao Shen; Yizhi Liu; Gang Chen
Journal:  Cell Transplant       Date:  2018-12-04       Impact factor: 4.064

7.  miR-92b-3p-TSC1 axis is critical for mTOR signaling-mediated vascular smooth muscle cell proliferation induced by hypoxia.

Authors:  Jihui Lee; Jeongyeon Heo; Hara Kang
Journal:  Cell Death Differ       Date:  2018-12-05       Impact factor: 15.828

8.  Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles.

Authors:  Thomas Ravn Lassen; Jesper Just; Marie Vognstoft Hjortbak; Nichlas Riise Jespersen; Katrine Tang Stenz; Tingting Gu; Yan Yan; Junyi Su; Jakob Hansen; Rikke Bæk; Malene Møller Jørgensen; Jens Randel Nyengaard; Steen Buus Kristiansen; Kim Ryun Drasbek; Jørgen Kjems; Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2021-03-10       Impact factor: 17.165

9.  Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.

Authors:  Zhi-Yu Duan; Guang-Yan Cai; Ru Bu; Yang Lu; Kai Hou; Xiang-Mei Chen
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.